Inhibitory effects of inhaled complex traditional Chinese medicine on early and late asthmatic responses induced by ovalbumin in sensitized guinea pigs

Department of Life Sciences, National Cheng Kung University, Tainan 701, Taiwan.
BMC Complementary and Alternative Medicine (Impact Factor: 2.02). 09/2011; 11(1):80. DOI: 10.1186/1472-6882-11-80
Source: PubMed


Many formulae of traditional Chinese medicines (TCMs) have been used for antiasthma treatment dating back many centuries. There is evidence to suggest that TCMs are effective as a cure for this allergenic disease administered via gastric tubes in animal studies; however, their efficacy, safety and side effects as an asthmatic therapy are still unclear.
In this study, guinea pigs sensitized with ovalbumin (OVA) were used as an animal model for asthma challenge, and the sensitization of animals by bronchial reactivity to methacholine (Mch) and the IgE concentration in the serum after OVA challenge were estimated. Complex traditional Chinese herbs (CTCM) were administered to the animals by nebulization, and the leukocytes were evaluated from bronchoalveolar lavage fluid (BALF).
The results showed that inhalation of CTCM could abolish the increased lung resistance (13-fold increase) induced by challenge with OVA in the early asthmatic response (EAR), reducing to as low as baseline (1-fold). Moreover, our results indicated higher IgE levels (range, 78-83 ng/ml) in the serum of sensitized guinea pigs than in the unsensitized controls (0.9 ± 0.256 ng/ml). In addition, increased total leukocytes and higher levels of eosinophils and neutrophils were seen 6 hours after challenge, and the increased inflammatory cells were reduced by treatment with CTCM inhalation. The interleukin-5 (IL-5) level in BALF was also reduced by CTCM.
Our findings indicate a novel method of administering traditional Chinese medicines for asthma treatment in an animal model that may be more effective than traditional methods.

Download full-text


Available from: Oi-Tong Mak
  • Source
    • "These Chinese medicines are administered orally, and the mechanisms of their effects remain unclear. In our previous study, we demonstrated that a CTCM administered in nebulized form through the intratracheal route was effective against early-phase air-flow obstruction and inhibited IL-5 in bronchoalveolar lavage fluid (BALF) in ovalbumin (OVA)-sensitized guinea pigs [28]. The mechanism of the effect on asthmatic responses in sensitized guinea pigs after treatment with a CTCM is still unclear. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Traditional Chinese medicines have been used for anti-asthma treatment for several centuries in many Asian countries, and have been shown to effectively relieve symptoms. Our previous study demonstrated that a complex traditional Chinese medicine (CTCM) administered in nebulized form through the intratracheal route is effective against early-phase air-flow obstruction and can inhibit IL-5 production in ovalbumin (OVA)-sensitized guinea pigs. However, the antiasthmatic mechanisms of CTCMs are still unclear. Methods: In this study, we examined the underlying mechanism of a CTCM that we used in our previous study in order to ascertain its function in the early-phase response to OVA challenge. Results: We found that the inhibition of bronchoconstriction by the CTCM was attenuated by pretreatment with propranolol, suggesting that the CTCM has a bronchodilator effect that is associated with beta-adrenergic receptor. Our results also showed that the CTCM inhibited histamine and IL-4 secretion in the OVA-induced airway hypersensitivity in guinea pigs at 5 min post-OVA challenge, and in vitro study revealed that the CTCM is able to stabilize mast cells. Conclusion: In conclusion, our results suggested that the CTCM is a kind of bronchodilator and also a mast cell stabilizer. Our findings provide useful information regarding the possible mechanism of the CTCM, and show its potential for application in the treatment of allergenic airway disease.
    Full-text · Article · Jul 2013 · BMC Complementary and Alternative Medicine
  • [Show abstract] [Hide abstract]
    ABSTRACT: Asthma prevalence has increased in recent years and is characterized by airway hyperresponsiveness and inflammation. Many patients report using alternative therapies to self-treat asthma symptoms as adjuncts to short- and long-acting β-agonists and inhaled corticosteroids (ICS). As many as 40% of asthmatics use herbal therapies to manage asthma symptoms, often without proven efficacy or known mechanism(s) of action. Therefore, it is important to investigate both the therapeutic and possible detrimental effects of isolated components of herbal treatments on the airway. We hypothesized that ginger and its active components induce bronchodilation by modulating intracellular calcium ([Ca2+]i) in airway smooth muscle (ASM). In isolated human ASM, ginger caused significant and rapid relaxation. Four purified constituents of ginger were subsequently tested for ASM relaxant properties in both guinea pig and human trachea. [6]-gingerol, [8]-gingerol and [6]-shogaol induced rapid relaxation of pre-contracted ASM (100-300μM), while [10]-gingerol failed to relax. In human ASM cells, exposure to [6]-gingerol, [8]-gingerol, and [6]-shogaol, but not [10]-gingerol (100μM), blunted subsequent Ca2+ responses to bradykinin (10 μM) and S-(-)-Bay K 8644 (10 μM). In A/J mice, nebulization of [8]-gingerol (100 μM) 15 minutes prior to methacholine challenge significantly attenuated airway resistance compared to vehicle. Taken together, these novel data show that ginger and its isolated active components, [6]-gingerol, [8]-gingerol, and [6]-shogaol, relax ASM and [8]-gingerol attenuates airway hyperresponsiveness in part by altering [Ca2+]i regulation. These purified compounds may provide a therapeutic option alone, or in combination with accepted therapeutics including β2-agonists in airway diseases such as asthma.
    No preview · Article · Oct 2012 · American Journal of Respiratory Cell and Molecular Biology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Interleukin-1 beta (IL-1β) plays pivotal roles in the progression of allergic airway inflammation. This study aims to determine whether the blockade of IL-1β can inhibit airway inflammation in guinea pigs with allergic asthma induced by the inhalation of aerosolized ovalbumin (OVA). Healthy guinea pigs treated with saline were used as normal controls (group C). The guinea pigs with allergic asthma induced by the inhalation of aerosolized OVA were randomly divided into three groups: (1) the M group containing negative control animals treated with saline; (2) the Z1 group containing animals treated by the inhalation of atomized 0.1% anti-IL-1β immunoglobulin yolk (IgY); and (3) the Z2 group containing positive control animals that were treated with budesonide. The inflammatory cells in the peripheral blood (PB) and bronchoalveolar lavage fluid (BALF) were evaluated using methylene blue and eosin staining. Cytokine concentrations were measured using an enzyme-linked immunosorbent assay. Pulmonary sections were examined using hematoxylin-eosin staining. Allergic inflammation and damage to the pulmonary tissues were decreased in the Z1 group compared to the M group. Eosinophils and neutrophils in the PB and BALF were significantly decreased in the Z1 group compared to the M group (P<0.05). Treatment with anti-IL-1β IgY significantly reduced the levels of IL-1β, IL-4, IL-8, IL-13, TNF-α, TGF-β1 and IgE in the BALF (P<0.05). The inhalation of aerosolized anti-IL-1β IgY inhibits pathological responses in the pulmonary tissues of guinea pigs with allergic asthma. The inhibitory activity may be due to the decrease in the numbers of eosinophils and neutrophils and the reduced levels of inflammatory cytokines and IgE in the PB and BALF.
    No preview · Article · Dec 2013 · Molecular Immunology
Show more